// App-Quantinova.ai

P139 : Rituximab in a large UK centre during the COVID-19 pandemic: the effects of employing a reduced dosing regimen on clinical response in Rheumatoid Arthritis patients

Researchers

Presenter

  • Joanna McLorinan

Principal Investigators

  • Maria Slade

  • Chi-han Leong

  • Josie Baker

  • Lynda Bailey

  • Jacqueline Nam

  • Lesley-Anne Bissell

  • Paul Emery

  • Shouvik Dass

  • Benazir Saleem

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved